Bill Ackman's nightmare stock is getting kicked around again

What more does the market want from Valeant Pharmaceuticals?
The stock fell over 5% during Friday's trading day. The news of the day, though, was that the company had completed a $1.3 billion asset sale to L'Oreal, something investors were clamoring for during the company's earnings call on Tuesday, as Valeant is holding around $30 billion in debt and could use the cash from some asset sales.
So, it's interesting that despite making a move that investors were looking for, the company is still ge